Bank Julius Baer & Co. Ltd, Zurich Amgen Inc Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$25.6 Billion
Q3 2024

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Amgen Inc stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 24,473 shares of AMGN stock, worth $6.66 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

24,473

Previous 35,485 31.03%

Holding current value

$6.66 Million

Previous $11.1 Million 28.88%

% of portfolio

0.03%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$309.38 - $337.38 $3.41 Million - $3.72 Million	-11,012 Reduced 31.03%	24,473 $7.89 Million
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $116 Million - $141 Million	-440,964 Reduced 92.55%	35,485 $11.1 Million
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $34.8 Million - $42 Million	129,522 Added 37.33%	476,449 $135 Million
Q4 2023 May 16, 2024	SELL	$255.7 - $288.46 $95 Million - $107 Million	-371,410 Reduced 77.95%	105,039 $30.3 Million
Q4 2023 May 16, 2024	BUY	$255.7 - $288.46 $61.9 Million - $69.8 Million	241,888 Added 230.28%	346,927 $99.9 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $4.04 Million - $4.56 Million	15,813 Added 4.78%	346,927 $99.9 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $4.79 Million - $5.95 Million	21,926 Added 7.09%	331,114 $89 Million
Q2 2023 Jul 24, 2023	BUY	$214.27 - $253.37 $66.2 Million - $78.3 Million	309,188 New	309,188 $68.6 Million
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $254,239 - $309,875	1,126 Added 0.36%	311,435 $75.3 Million
Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $63,212 - $80,318	276 Added 0.09%	310,309 $81.5 Million
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $1.27 Million - $1.43 Million	5,645 Added 1.85%	310,033 $69.9 Million
Q2 2022 Jul 22, 2022	BUY	$230.71 - $256.74 $68.9 Million - $76.7 Million	298,611 Added 5168.96%	304,388 $74.1 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $229,575 - $253,970	-1,047 Reduced 15.34%	5,777 $1.4 Million
Q4 2021 Feb 15, 2022	SELL	$198.88 - $227.6 $2.44 Million - $2.8 Million	-12,284 Reduced 64.29%	6,824 $1.54 Million
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $190,406 - $223,083	897 Added 4.93%	19,108 $4.06 Million
Q2 2021 Jul 23, 2021	BUY	$233.58 - $259.14 $577,176 - $640,334	2,471 Added 15.7%	18,211 $4.44 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $416,081 - $484,875	-1,875 Reduced 10.64%	15,740 $3.92 Million
Q4 2020 Feb 24, 2021	SELL	$216.38 - $257.67 $5.16 Million - $6.14 Million	-23,843 Reduced 57.51%	17,615 $4.05 Million
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $4.48 Million - $5.34 Million	20,722 Added 99.93%	41,458 $4.05 Million
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $1.64 Million - $1.83 Million	7,005 Added 51.02%	20,736 $5.27 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $294,736 - $361,682	1,490 Added 12.17%	13,731 $3.24 Million
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $2.23 Million - $2.96 Million	12,241 New	12,241 $2.48 Million

Others Institutions Holding AMGN

# of Institutions

3,097

Shares Held

406M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Amgen Inc Transaction History